Condition: Local Neoplasm Recurrence · Distantly Metastatic Malignant Neoplasm · Death · Sponsor: Danish Breast Cancer Cooperative Group
All early breast cancer patients are offered adjuvant breast radiation therapy (RT) after breast conserving surgery for an early breast cancer. Breast cancer is heterogeneous, and selected patients have a very low gain from RT, whilst they still have risk of acute and late side effects from RT. This trial will try identify selection criteria for low risk breast cancer patients who can safely omit adjuvant RT without unacceptable high risk of local failure.
This description comes directly from the study's public registry record.
Birgitte V Offersen, PhD · +45 28838012 · bvo@oncology.au.dk
Always discuss trial participation with your own doctor first.
| Ponticia Universidad Catolica de Chile | Santiago, Chile | Recruiting |
| Aalborg University Hospital | Aalborg, Denmark | Recruiting |
| Aarhus University Hospital | Aarhus, Denmark | Recruiting |
| Rigshospitalet | Copenhagen, Denmark | Recruiting |
| Herlev Hospital | Herlev, Denmark | Recruiting |
| Naestved Hospital | Næstved, Denmark | Recruiting |
| Odense University Hospital | Odense, Denmark | Recruiting |
| Vejle Hospital | Vejle, Denmark | Recruiting |
| Haukeland HUS | Bergen, Norway | Recruiting |
| Nordlandssykehuset | Bodø, Norway | Recruiting |
| Kristiansand Hospital | Kristiansand, Norway | Recruiting |
| Oslo University Hospital, Radiumhospitalet | Oslo, Norway | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03646955